Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.
about
A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in ratsScience review: recombinant human erythropoietin in critical illness: a role beyond anemia?Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats.Mesenteric lymph reperfusion exacerbates spleen injury caused by superior mesenteric artery occlusion shockRecombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma.Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis modelErythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease.Erythropoietin and the heart: facts and perspectives.The nonhematopoietic effects of erythropoietin in skin regeneration and repair: from basic research to clinical use.Erythropoietin reverts cognitive impairment and alters the oxidative parameters and energetic metabolism in sepsis animal model.Effects of darbepoetin-alpha in spinal cord ischemia-reperfusion injury in the rabbit
P2860
Q24673298-08314C3F-86D6-449E-B09A-11EA15222ECEQ24799799-3DB05F58-BC9E-4451-B932-1C44C5F7CF4AQ30480727-1425C5EB-9022-4924-87C6-C709B1F0B157Q33822192-608A0558-27AC-45C5-AD15-E78036B8E0B3Q34035654-5821A7B9-B5C0-4FD5-B51E-0F3A21E70AA6Q34132516-DB4F8318-892E-4DA6-A36E-AE6965483F73Q34960679-7B523EFE-868D-41DB-A8BA-770687E8B0AEQ35144156-46B397E3-55FF-4A0B-B9E9-B7289DBE7B27Q36392457-804512C6-83FF-47DC-B59C-067DCEA06E2EQ36529533-8FDC7D5F-4144-4D1D-8F10-FF5E287C5F24Q37798565-B9FB28AF-F78D-4A07-B348-FBAC54FA0874Q37995093-A4D89601-7DCB-4721-964F-2E38F6B9C2B8Q50966539-B101A98A-8380-4D1C-BF96-50245E5A611AQ56967412-E4D82312-89D9-4A3D-AD4E-2A2F5D173DB6
P2860
Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Recombinant human erythropoiet ...... nchnic artery occlusion shock.
@en
Recombinant human erythropoiet ...... nchnic artery occlusion shock.
@nl
type
label
Recombinant human erythropoiet ...... nchnic artery occlusion shock.
@en
Recombinant human erythropoiet ...... nchnic artery occlusion shock.
@nl
prefLabel
Recombinant human erythropoiet ...... nchnic artery occlusion shock.
@en
Recombinant human erythropoiet ...... nchnic artery occlusion shock.
@nl
P2093
P2860
P356
P1476
Recombinant human erythropoiet ...... anchnic artery occlusion shock
@en
P2093
A P Caputi
C Quartarone
D Altavilla
F Squadrito
G Squadrito
P2860
P304
P356
10.1038/SJ.BJP.0702521
P407
P577
1999-05-01T00:00:00Z